| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| EDGEMOND JAMES | CFO AND TREASURER | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 05 Nov 2025 | 0001636178 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $3.07M | +21K | +258.68% | $146.03 | 29.1K | 04 Nov 2025 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | -$42.3K | -98 | -0.34% | $432.09 | 29K | 04 Nov 2025 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | -$465K | -1.07K | -3.7% | $432.86 | 27.9K | 04 Nov 2025 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | -$656K | -1.51K | -5.41% | $433.78 | 26.4K | 04 Nov 2025 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | -$730K | -1.68K | -6.35% | $434.96 | 24.8K | 04 Nov 2025 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | -$2.65M | -6.09K | -24.59% | $435.81 | 18.7K | 04 Nov 2025 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | -$3.2M | -7.32K | -39.2% | $436.78 | 11.4K | 04 Nov 2025 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | -$1.2M | -2.75K | -24.25% | $437.74 | 8.6K | 04 Nov 2025 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | -$158K | -360 | -4.19% | $438.50 | 8.24K | 04 Nov 2025 | Direct | F1, F9 |
| transaction | UTHR | Common Stock | Sale | -$52.7K | -120 | -1.46% | $439.51 | 8.12K | 04 Nov 2025 | Direct | F1, F10 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Options | Options Exercise | $0 | -21K | -40.14% | $0.00 | 31.3K | 04 Nov 2025 | Common Stock | 21K | $146.03 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025. |
| F10 | This transaction was executed in multiple trades at prices ranging from $439.37 to $439.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $431.31 to $432.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $432.31 to $433.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $433.31 to $434.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $434.31 to $435.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $435.31 to $436.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $436.31 to $437.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $437.31 to $438.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $438.34 to $438.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |